Samsung Pharm Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samsung Pharm Co Ltd with three other
companies in this sector in KOREA (SOUTH) :
Kyung Nam Pharm Company Limited
sales of 44.81 billion Korean Won [US$38.53 million]
of which 37%
was Generic medicine),
Ilsung Pharmaceuticals Company Limited
(48.41 billion Korean Won [US$41.63 million]
of which 53%
was Refinement), and
Jin Yang Pharmaceuticals Co Ltd
(47.35 billion Korean Won [US$40.72 million]
of which 100%
was medicine and medical supplies).
During the year ended December of 2019, sales at
Samsung Pharm Co Ltd were 44.57 billion Korean Won (US$38.33 million).
decrease of 4.1%
versus 2018, when the company's sales were 46.48 billion Korean Won .
Contributing to the drop in overall sales was the 34.3% decline
in Health Food Segment, from 3.72 billion Korean Won to 2.44 billion Korean Won .
There were also decreases in sales in
Pharmaceuticals Segment (down 1.8% to 42.12 billion Korean Won )